Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Assets Average (2021 - 2024)

Pasithea Therapeutics (KTTA) has disclosed Assets Average for 4 consecutive years, with $18.2 million as the latest value for Q3 2024.

  • Quarterly Assets Average fell 47.24% to $18.2 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $18.2 million through Sep 2024, down 47.24% year-over-year, with the annual reading at $35.6 million for FY2023, 27.62% down from the prior year.
  • Assets Average hit $18.2 million in Q3 2024 for Pasithea Therapeutics, down from $20.0 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $52.2 million in Q1 2022 to a low of $18.2 million in Q3 2024.
  • Historically, Assets Average has averaged $37.4 million across 4 years, with a median of $38.6 million in 2021.
  • Biggest five-year swings in Assets Average: grew 27.47% in 2022 and later plummeted 50.03% in 2024.
  • Year by year, Assets Average stood at $37.2 million in 2021, then grew by 27.47% to $47.4 million in 2022, then tumbled by 40.1% to $28.4 million in 2023, then tumbled by 36.06% to $18.2 million in 2024.
  • Business Quant data shows Assets Average for KTTA at $18.2 million in Q3 2024, $20.0 million in Q2 2024, and $24.3 million in Q1 2024.